HYPMY (Hypera) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HYPMY Hypera SA HYPMY
87 GF Score
Price $4.09
GF Value $6.20
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Hypera Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HYPMY
87GF Score
Hypera SA HYPMY
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hypera (HYPMY) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of $4.09 is trading 34% below its estimated GF Value™ of $6.20. GuruFocus considers Hypera to be Possible Value Trap.

Key valuation signals for HYPMY:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $6.20 vs. price of $4.09 (34% below fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the HYPMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Other Exchanges HM6A:GermanyHYPE3:Brazil
Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
87GF Score

Get the complete analysis for HYPMY

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.09
Price
$6.20
GF Value